Ultra-rapid Opiate Detoxification Using Deep Sedation and Prior Oral Buprenorphine Preparation.
Sponsor
Assaf-Harofeh Medical Center (Other)
Overall Status
Unknown status
CT.gov ID
NCT01008072
Collaborator
(none)
40
1
Study Details
Study Description
Brief Summary
The methods of detoxification under general anesthesia have been criticized because of limited data on safety and long-term follow-up. Premedication with buprenorphine has been advocated to improve safety. In current study we want to evaluate the importance of buprenorphine preparation in rapid opioid detoxification process, under general anesthesia.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
Study Design
Study Type:
Observational
Anticipated Enrollment
:
40 participants
Observational Model:
Case-Control
Time Perspective:
Retrospective
Study Start Date
:
Dec 1, 2009
Anticipated Primary Completion Date
:
Dec 1, 2009
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
without buprenorphine preparation
|
|
with buprenorphine preparation
|
Outcome Measures
Primary Outcome Measures
Eligibility Criteria
Criteria
Ages Eligible for Study:
18 Years
and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
- Opioid addiction
Exclusion Criteria:
- Age < 18 Pregnancy
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Anesthesiology department, Assaf-Harofeh MC | Beer-Yaakov, Zrifin | Israel | 70300 |
Sponsors and Collaborators
- Assaf-Harofeh Medical Center
Investigators
None specified.Study Documents (Full-Text)
None provided.More Information
Publications
None provided.Responsible Party:
,
,
ClinicalTrials.gov Identifier:
NCT01008072
Other Study ID Numbers:
- 173/09
First Posted:
Nov 5, 2009
Last Update Posted:
Nov 5, 2009
Last Verified:
Nov 1, 2009
Additional relevant MeSH terms: